Back to TCRX
MORGAN STANLEY TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
17
Latest value
$22K
Q3 2026
Peak value
$1.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.1M |
| Q3 2025 | $143K |
| Q3 2025 | $269K |
| Q3 2025 | $3K |
| Q4 2025 | $35K |
| Q4 2025 | $51K |
| Q4 2025 | $140K |
| Q1 2026 | $31K |
| Q1 2026 | $31K |
| Q1 2026 | $114K |
| Q2 2026 | $41K |
| Q2 2026 | $629 |
| Q2 2026 | $1K |
| Q2 2026 | $151K |
| Q3 2026 | $10K |
| Q3 2026 | $877 |
| Q3 2026 | $22K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $22K | 71.1K | — | — |
| Q3 2026 | $877 | 2.8K | — | — |
| Q3 2026 | $10K | 30.8K | — | — |
| Q2 2026 | $151K | 153.9K | — | — |
| Q2 2026 | $1K | 1.4K | — | — |
| Q2 2026 | $629 | 642 | — | — |
| Q2 2026 | $41K | 41.9K | — | — |
| Q1 2026 | $114K | 112.5K | — | — |
| Q1 2026 | $31K | 30.3K | — | — |
| Q1 2026 | $31K | 30.8K | — | — |
| Q4 2025 | $140K | 140.4K | — | — |
| Q4 2025 | $51K | 50.6K | — | — |
| Q4 2025 | $35K | 34.8K | — | — |
| Q3 2025 | $3K | 1.6K | — | — |
| Q3 2025 | $269K | 148.0K | — | — |
| Q3 2025 | $143K | 78.5K | — | — |
| Q3 2025 | $1.1M | 619.4K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M